new treatments
new therapies
new models
new therapeutic target pathways
genetic types of Batten disease
development of new therapeutic options
Triage new compound treatments
disease biology
small molecule treatments
juvenile CLN3 disease
curative treatments
testing therapies
existing small molecule therapy
biochemical therapeutic target pathways
therapy development
mouse models
effective evaluation of preclinical therapies
specific gene
gene function
CLN7 diseases
pluripotent stem cell models
mediterranean Europe
genetic disorders
goal of BATCure
type of NCL
novel mechanism
high-throughput small vertebrate model
novel integrated strategy
Existing palliative treatment
group of rare lysosomal diseases - neuronal ceroid lipofuscinoses
yeast
zebrafish
PNS
epilepsy
motor decline
progressive dementia
visual failure
brain
cardiology
spinal cord
CLN6
technologies
body
children
tools
worsening effects
long period of complete dependence
metabolic changes
comprehensive natural history
CNS influence
patients
diagnostics
clinical trials
burden of seizures
control
families
combined incidence of
NCLs
premature death